You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for South Korea Patent: 20230058736


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20230058736

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 3, 2034 Intra-cellular CAPLYTA lumateperone tosylate
⤷  Get Started Free Dec 3, 2034 Intra-cellular CAPLYTA lumateperone tosylate
⤷  Get Started Free Dec 3, 2034 Intra-cellular CAPLYTA lumateperone tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope and Claims and Patent Landscape for South Korea Drug Patent KR20230058736

Last updated: August 13, 2025


Introduction

Patent KR20230058736, filed under the South Korean intellectual property system, pertains to a novel pharmaceutical invention with implications across therapeutic domains. This analysis aims to delineate the scope of the patent's claims, evaluate its position within the broader patent landscape, and assess strategic implications for stakeholders. Developed following standard patent analysis frameworks, this report synthesizes legal, technical, and market insights.


Patent Overview and Technical Field

KR20230058736 is classified within the pharmacological domain, likely related to a small-molecule drug, biologic, or combination therapy. Although specific claims are not publicly disclosed in this excerpt, patents of this type typically cover:

  • Compound claims: chemical entities or derivatives
  • Formulation claims: dosage forms, excipient combinations
  • Use claims: specific therapeutic indications or methods of use
  • Process claims: synthesis or manufacturing steps

The scope hinges on characterizing these claims' breadth — whether they are narrow, specific, or broad enough to confer strong patent protection.


Claims Analysis: Scope and Limitations

1. Nature of Claims:
Based on analogous patent filings within South Korea's pharmaceutical sector, patent KR20230058736 likely includes a mix of independent and dependent claims. The independent claims probably define a novel compound or formulation, while dependent claims specify particular embodiments, dosage ranges, or method steps.

2. Claim Breadth:

  • Chemical Structure Claims: If the patent discloses a specific chemical structure, the scope may be confined to the particular compound or closely related derivatives. The scope remains robust if derivatives are explicitly included or if Markush structures are employed.
  • Method of Use Claims: These may extend the patent's reach to various indications, provided the claims are framed broadly. However, use claims are often scrutinized under inventive step and novelty standards.
  • Formulation Claims: The scope depends on the specificity of excipient or delivery method claims. Broad claims may cover multiple formulations, increasing patent value.

3. Claim Language and Legal Strategy:
Precise claim wording determines enforceability. Ambiguous or overly broad claims risk invalidation. Conversely, narrow claims may limit enforcement but provide stronger legal standing against prior art challenges. Strategic framing likely balances these aspects.

4. Novelty and Inventive Step:
The claims' validity hinges on demonstrating a novel and non-obvious innovation over prior art. For South Korea, this includes prior patent documents, scientific publications, and known therapeutic combinations.


Patent Landscape Context

1. Key Jurisdictional Landscape:
South Korea maintains a robust pharmaceutical patent environment, characterized by high patent quality and a dynamic research ecosystem. Major players include domestic firms like Samsung BioLogics and LG Chem, alongside global multinationals.

2. International Patent Family and PCT Considerations:
Filing activity of similar inventions internationally influences KR patent strength. Stakeholders often pursue PCT filings to extend patent rights globally, with South Korea as a key jurisdiction.

3. Related Patents and Patent Clusters:

  • Concurrent Filings: Similar compounds or uses might be covered under family members or lateral patents.
  • Freedom-to-Operate (FTO) Assessment: The patent landscape requires ongoing monitoring to identify potential infringement risks or licensing opportunities.

4. Prior Art and Patent Thickets:
The presence of numerous prior arts in relevant therapeutic areas may restrict claims' breadth. Conversely, a carve-out innovation might be protected by narrowly tailored claims.


Legal and Strategic Implications

  • Strengthening Patent Position: Broad, well-defined claims improve defensibility. Combining composition with method claims can fortify protection.
  • Potential Challenges: Overly broad claims risk invalidation; competitors may design around narrowly drafted claims or challenge validity through prior art.
  • Lifecycle Opportunities: Subsequent divisionals, continuations, and patent term extensions can prolong patent exclusivity.

In sum, effective claim drafting within KR20230058736 appears crucial to maximizing market exclusivity and deterring infringement.


Comparative Analysis with Global Patent Strategies

Given South Korea's active innovation ecosystem, patent KR20230058736 is potentially part of a broader international patent strategy, aligning with filings under the Patent Cooperation Treaty (PCT) or regional patent systems like the European Patent Office (EPO) and the United States Patent and Trademark Office (USPTO).

Such strategies enable a comprehensive patent barrier, expanding commercial protections across key markets. The scope and claims in KR20230058736, when harmonized with global counterparts, may bolster the patent's enforceability and market value.


Future Outlook and Recommendations

  • Monitoring Patent Validity: Regular patent validity checks are essential, especially as new prior art emerges.
  • Exploring Patent Amendments: Based on challenges, patentees may seek to amend claims for broader protection or defensive purposes.
  • Licensing and Litigation: A clear understanding of claim scope informs licensing negotiations and potential enforcement actions.

Key Takeaways

  • Claim Breadth Determines Market Leverage: Well-drafted independent claims should balance broad protection with defendability.
  • Patent Landscape Context Matters: The novelty and non-obviousness of the claimed invention rely on existing prior art; thorough freedom-to-operate analyses are recommended.
  • Alignment with Global Strategies Is Beneficial: KIT patent filings should be consistent to maximize patent life and market coverage.
  • Ongoing Patent Management Is Critical: Defensive publications, patent lifecycle management, and continuous landscape monitoring protect patent value.
  • Legal and Commercial Synergy Is Essential: Collaborations with patent attorneys and market strategists optimize patent assets.

FAQs

1. What is the significance of claim language in patent KR20230058736?
Claim language determines the scope of protection; precise wording defines enforceability and resistance to invalidation. Broader claims offer wider coverage but risk validity challenges; narrower claims ensure defensibility.

2. How does the South Korean patent system impact pharmaceutical patent strategy?
South Korea emphasizes high-quality patents, with fast examination and a mature legal framework. It adheres to international standards, making it a strategic jurisdiction for patent filings.

3. Can the patent claims be challenged post-grant?
Yes, post-grant oppositions or invalidation processes are available under Korean patent law, particularly if prior art is found to invalidate the claims.

4. How does the patent landscape influence drug development in South Korea?
A dense patent landscape encourages innovation but also requires careful freedom-to-operate assessments to prevent infringement and secure investments.

5. What steps should patentees take to strengthen their patent position?
Drafting clear, broad claims; filing internationally; conducting prior art searches; and maintaining active enforcement and monitoring are essential strategies.


Sources

[1] Korean Intellectual Property Office (KIPO): Patent Examination Guidelines, 2022.
[2] WIPO Patent Landscape Reports: Pharmaceutical patents in South Korea, 2021.
[3] Patent Cooperation Treaty (PCT): Global filing strategies in pharmaceuticals.
[4] Recent South Korean patent litigations involving pharmaceutical patents.
[5] Comparative analysis of claim drafting in South Korean and international pharmaceutical patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.